What are the recommended evaluation and management steps for a patient who wakes up with fatigue and a morning headache?

Evaluation and Management of Morning Headache with Fatigue

Screen immediately for obstructive sleep apnea (OSA), as morning headache is a cardinal symptom of sleep-disordered breathing and treatment with CPAP resolves headache completely within one month in most cases. 1

Initial Red-Flag Assessment

Before attributing symptoms to a primary headache disorder or sleep pathology, exclude secondary causes by asking about:

• Thunderclap onset (sudden, severe "worst headache of life") suggesting subarachnoid hemorrhage 1
• Progressive worsening pattern over days to weeks 2
• New neurological deficits (weakness, numbness, vision changes, speech difficulty, ataxia) 2
• Fever, neck stiffness, or altered mental status suggesting meningitis/encephalitis 2
• Recent head trauma within the past 3 months 2
• Age >50 years with new-onset headache (consider temporal arteritis, mass lesion) 2
• Cancer history or immunosuppression (HIV, transplant, chemotherapy) 2

If any red flags are present, obtain urgent brain MRI with and without contrast and consider lumbar puncture if imaging is negative but clinical suspicion remains high. 2

Obstructive Sleep Apnea Screening (Priority #1)

Morning headache occurring on awakening that improves within 2–4 hours is highly specific for OSA and should trigger immediate evaluation. 1, 3

High-Risk Features Requiring Sleep Study

• Witnessed apneas or gasping/choking at night 1
• Loud snoring (reported by bed partner) 1
• Excessive daytime sleepiness not explained by insufficient sleep duration 1
• Nocturia (≥2 episodes per night) 1
• Nonrefreshing sleep despite adequate time in bed 1
• Obesity (BMI ≥30 kg/m²) 1
• Hypertension (especially treatment-resistant) 1
• Cardiovascular disease (heart failure, coronary artery disease, atrial fibrillation, stroke/TIA) 1

Diagnostic Pathway

• In-laboratory polysomnography (PSG) is the gold standard and routinely indicated for suspected OSA 1
• Home sleep apnea testing (portable monitor) may be used only in patients with high pretest probability of moderate-to-severe OSA without major comorbidities (pulmonary disease, neuromuscular disease, heart failure) 1
• PSG is mandatory (not optional) for patients with cardiovascular comorbidities, as these patients require comprehensive sleep architecture assessment 1

Treatment and Expected Outcome

• CPAP therapy is first-line treatment for confirmed OSA 1
• Morning headaches resolve completely within 1 month of adequate CPAP adherence in the majority of patients 4
• Follow-up PSG with CPAP titration is indicated if symptoms persist despite treatment 1

Migraine Evaluation (If OSA Excluded)

If OSA screening is negative or headache persists after CPAP optimization, evaluate for migraine without aura, which commonly presents with morning headache. 1, 5

Diagnostic Criteria for Migraine

• Headache duration 4–72 hours (untreated or unsuccessfully treated) 1
• At least 2 of the following characteristics:
  • Unilateral location 1
  • Pulsating quality 1
  • Moderate-to-severe intensity (interferes with daily activities) 1
  • Aggravation by routine physical activity (walking, climbing stairs) 1
• At least 1 associated symptom:
  • Nausea and/or vomiting 1
  • Photophobia (light sensitivity) and phonophobia (sound sensitivity) 1
• ≥5 lifetime attacks meeting above criteria 1

Migraine-Specific Questions

• "End-of-day" or "second-half-of-day" headache that improves when lying flat suggests orthostatic component (consider spontaneous intracranial hypotension) 1
• Triggers: sleep deprivation, stress, menstruation, alcohol, specific foods 1
• Family history of migraine (present in 60–90% of cases) 1

Sleep Disorder Screening Beyond OSA

Morning headache can result from multiple sleep pathologies that require targeted questioning. 3, 6

Insomnia Assessment

• Difficulty falling asleep (sleep latency >30 minutes) 3
• Frequent nocturnal awakenings with difficulty returning to sleep 3
• Early morning awakening (≥30 minutes before desired wake time) with inability to return to sleep 3
• Total sleep time <6 hours on most nights 3
• Daytime consequences: fatigue, irritability, concentration difficulty 3

Insomnia is the most common sleep complaint in chronic headache populations and often coexists with depression/anxiety. 3, 6

Circadian Rhythm Disorder

• Delayed sleep phase: Cannot fall asleep until 2–6 AM, extreme difficulty waking for morning obligations, feels best in evening/night 6
• Advanced sleep phase: Falls asleep 6–9 PM, wakes 2–5 AM, cannot return to sleep 6
• Irregular sleep-wake pattern: No consistent sleep schedule, multiple daytime naps 6

Medication-Overuse Headache (MOH)

• Headache ≥15 days per month for >3 months 1, 5
• Regular overuse of acute headache medication:
  • NSAIDs, acetaminophen, or aspirin ≥15 days/month 1, 5
  • Triptans, ergots, opioids, or combination analgesics ≥10 days/month 1, 5
• Headache worsens or fails to improve despite acute medication use 5

MOH creates a vicious cycle where morning headache prompts immediate medication use, perpetuating daily headache. 5

Diagnostic Testing Algorithm

When Neuroimaging Is Not Required

• Typical migraine pattern (≥5 prior similar episodes) 2
• Normal neurological examination 2
• No red-flag features 2
• Stable headache pattern (not progressive) 2

When Neuroimaging Is Required

• Any red-flag feature listed above 2
• Atypical features: headache always same side, awakens from sleep (not just present on awakening), positional component 2
• New-onset headache after age 50 2
• Change in established headache pattern (frequency, severity, character) 2

MRI brain with and without contrast is preferred over CT for headache evaluation (except in acute trauma or suspected acute hemorrhage). 2

Management Strategy

If OSA Confirmed

• Initiate CPAP therapy immediately 1
• Educate patient that headache resolution typically occurs within 1 month of adherent CPAP use 4
• Schedule follow-up at 4–6 weeks to assess headache response and CPAP adherence 1
• If headache persists despite adequate CPAP use (≥4 hours/night, AHI <5), re-evaluate for coexisting primary headache disorder 1

If Migraine Confirmed (Without OSA)

Acute Treatment

• First-line for mild-to-moderate attacks: NSAIDs (ibuprofen 400–800 mg, naproxen 500–825 mg, or aspirin 1000 mg) taken at headache onset 4, 5
• Second-line for moderate-to-severe attacks or NSAID failure: Triptan (sumatriptan 50–100 mg, rizatriptan 10 mg, or eletriptan 40 mg) 4, 5
• Combination therapy (strongest recommendation): Triptan + NSAID (e.g., sumatriptan 100 mg + naproxen 500 mg) provides superior efficacy to either agent alone 4
• Critical frequency limit: Restrict all acute medications to ≤2 days per week (≤10 days per month) to prevent medication-overuse headache 4, 5

Preventive Therapy Indications

Initiate preventive therapy if patient meets any of the following: 5

• ≥2 migraine attacks per month causing disability ≥3 days 5
• Acute medication use >2 days per week 5
• Contraindication to or failure of acute treatments 5
• Patient preference for prevention over acute treatment 5

First-Line Preventive Medications

• Beta-blockers: Propranolol 80–240 mg/day (especially if hypertensive) 5
• Topiramate: 50–100 mg/day (especially if obese; expect weight loss) 5
• Amitriptyline: 30–150 mg at bedtime (especially if coexisting insomnia, depression, or tension-type headache) 5

Assess preventive efficacy after 2–3 months at therapeutic dose. 5

If Insomnia Identified

• Cognitive-behavioral therapy for insomnia (CBT-I) is first-line treatment (as effective as pharmacotherapy without side effects) 5, 3
• Sleep hygiene education:
  • Consistent sleep-wake schedule (including weekends) 5, 3
  • Avoid caffeine after noon 5
  • Limit alcohol (disrupts sleep architecture) 5, 3
  • Regular exercise (but not within 3 hours of bedtime) 5
  • Dark, quiet, cool bedroom environment 5
• Pharmacological options (if CBT-I insufficient):
  • Amitriptyline 25–50 mg at bedtime (dual benefit for migraine prevention and insomnia) 5, 6
  • Avoid benzodiazepines long-term (dependency risk, rebound insomnia) 6

If Medication-Overuse Headache Suspected

• Immediate withdrawal of overused medication (abrupt cessation, not gradual taper) 4
• Warn patient that headache may worsen for 2–10 days during withdrawal 4
• Do not substitute another acute medication during withdrawal period (perpetuates overuse cycle) 4
• Initiate preventive therapy immediately (topiramate or onabotulinumtoxinA for chronic migraine) 4, 5
• After 2–4 weeks, headache frequency typically decreases, allowing reassessment of baseline pattern 4

Comorbidity Management

Address modifiable risk factors that perpetuate morning headache: 5

• Obesity: Weight loss improves both OSA and migraine frequency 5
• Depression/anxiety: Screen with PHQ-9 and GAD-7; treat with CBT and/or SSRI/SNRI 5
• Poor sleep quality: Implement sleep hygiene measures and consider CBT-I 5, 3
• Excessive caffeine: Limit to ≤200 mg/day (≈2 cups coffee) consumed before noon 4

Critical Pitfalls to Avoid

• Never dismiss morning headache as "just stress" or "poor sleep" without screening for OSA—this is a treatable cause with complete headache resolution in most cases 1, 4
• Never allow unlimited acute medication use—strict ≤2 days/week limit prevents medication-overuse headache 4, 5
• Never prescribe opioids or butalbital-containing compounds for headache (high dependency risk, rebound headache, questionable efficacy) 4, 5
• Never initiate migraine preventive therapy without first ruling out and treating medication-overuse headache—MOH prevents response to preventives 5
• Never order brain MRI for typical migraine with normal examination and no red flags—this wastes resources and risks incidental findings prompting unnecessary further testing 2

Follow-Up and Monitoring

• Headache diary: Instruct patient to record daily headache frequency, severity (0–10 scale), duration, associated symptoms, triggers, and medication use 5
• Reassess at 4–6 weeks to evaluate treatment response and medication adherence 5
• If OSA treated: Verify CPAP adherence (download machine data) and repeat sleep study if symptoms persist 1
• If preventive therapy initiated: Allow 2–3 months at therapeutic dose before declaring failure; consider alternative preventive class if ineffective 5
• Refer to headache specialist if diagnosis uncertain, multiple preventives fail, or patient requires onabotulinumtoxinA or CGRP monoclonal antibodies 5